2011/862/EU: Commission Implementing Decision of 19 December 2011 approving certain amended programmes for the eradication and monitoring of animal diseases and zoonoses for the year 2011 and amending Decision 2010/712/EU as regards the financial contribution by the Union for programmes approved by that Decision (notified under document C(2011) 9478)

The amended programme for bovine brucellosis submitted by Portugal on 12 April 2011 is hereby approved for the period from 1 January 2011 to 31 December 2011.

The following amended programmes for the control of certain zoonotic salmonella in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo) are is hereby approved for the period from 1 January 2011 to 31 December 2011: (a) the programme submitted by Belgium on 26 July 2011; (b) the programme submitted by Latvia on 8 March 2011.

The following amended programmes for the control and monitoring of classical swine fever are hereby approved for the period from 1 January 2011 to 31 December 2011: (a) the programme submitted by Romania on 7 October 2011; (b) the programme submitted by Slovakia on 21 November 2011.

The amended survey programme for avian influenza in poultry and wild birds submitted by Denmark on 4 March 2011 is hereby approved for the period from 1 January 2011 to 31 December 2011.

The following amended programmes for the monitoring of transmissible spongiform encephalopathies (TSE), and for the eradication of bovine spongiform encephalopathy (BSE) and of scrapie are hereby approved for the period from 1 January 2011 to 31 December 2011: (a) the programme submitted by Belgium on 15 June 2011; (b) the programme submitted by the Czech Republic on 17 June 2011; (c) the programme submitted by Denmark on 8 June 2011; (d) the programme submitted by Germany on 14 June 2011; (e) the programme submitted by Estonia on 27 June 2011; (f) the programme submitted by Ireland on 29 June 2011; (g) the programme submitted by Spain on 1 July 2011; (h) the programme submitted by France on 13 July 2011; (i) the programme submitted by for Italy on 22 June 2011; (j) the programme submitted by Cyprus on 30 June 2011; (k) the programme submitted by Latvia on 28 June 2011; (l) the programme submitted by Luxembourg on 24 June 2011; (m) the programme submitted by Hungary on 29 June 2011; (n) the programme submitted by the Netherlands on 30 June 2011; (o) the programme submitted by Austria on 29 June 2011; (p) the programme submitted by Poland on 28 June 2011; (q) the programme submitted by Portugal on 29 June 2011; (r) the programme submitted by Slovenia on 8 June 2011; (s) the programme submitted by Slovakia on 30 June 2011; (t) the programme submitted by Finland on 22 June 2011; (u) the programme submitted by Sweden on 20 June 2011; (v) the programme submitted by the United Kingdom on 28 June 2011.

The following amended programmes for rabies are hereby approved for the period from 1 January 2011 to 31 December 2011: (a) the programme submitted by Romania on 23 September 2011; (b) the programme submitted by Finland on 15 September 2011.

The amended multiannual programme for rabies submitted by Slovenia on 16 September 2011 is hereby approved for the period from 1 January 2011 to 31 December 2012.

Decision 2010/712/EU is amended as follows: 1. Article 1 is amended as follows: (a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; (b) paragraph 2(c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 4600000 for Spain; (ii) EUR 3000000 for Italy; (iii) EUR 90000 for Cyprus; (iv) EUR 1040000 for Portugal; (v) EUR 1350000 for the United Kingdom.’; (c) in paragraph 3, points (a) to (d) are replaced by the following: ‘(a)for a rose bengal testEUR 0,24 per test;(b)for a SAT testEUR 0,24 per test;(c)for a complement fixation testEUR 0,48 per test;(d)for an ELISA testEUR 1,2 per test’; 2. Article 2 is amended as follows: (a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; (b) paragraph 2(c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 16000000 for Ireland; (ii) EUR 18500000 for Spain; (iii) EUR 5500000 for Italy; (iv) EUR 1440000 for Portugal; (v) EUR 26500000 for the United Kingdom.’; (c) in paragraph 3, points (a) and (b) are replaced by the following: ‘(a)for a tuberculin testEUR 2,4 per test;(b)for a gamma-interferon testEUR 6 per test’; 3. Article 3 is amended as follows: (a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; (b) paragraph 2(c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 160000 for Greece; (ii) EUR 9200000 for Spain; (iii) EUR 4200000 for Italy; (iv) EUR 85000 for Cyprus; (v) EUR 2260000 for Portugal.’; (c) in paragraph 3, points (a) and (b) are replaced by the following: ‘(a)for a rose bengal testEUR 0,24 per test;(b)for a complement fixation testEUR 0,48 per test;’; 4. Article 4 is amended as follows: (a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; (b) paragraph 2(c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 420000 for Belgium; (ii) EUR 10000 for Bulgaria; (iii) EUR 1700000 for the Czech Republic; (iv) EUR 0 for Denmark; (v) EUR 400000 for Germany; (vi) EUR 10000 for Estonia; (vii) EUR 10000 for Ireland; (viii) EUR 100000 for Greece; (ix) EUR 5200000 for Spain; (x) EUR 3000000 for France; (xi) EUR 300000 for Italy; (xii) EUR 20000 for Latvia; (xiii) EUR 5000 for Lithuania; (xiv) EUR 60000 for Hungary; (xv) EUR 10000 for Malta; (xvi) EUR 50000 for the Netherlands; (xvii) EUR 160000 for Austria; (xviii) EUR 50000 for Poland; (xix) EUR 1650000 for Portugal; (xx) EUR 100000 for Romania; (xxi) EUR 50000 for Slovenia; (xxii) EUR 60000 for Slovakia; (xxiii) EUR 20000 for Finland; (xxiv) EUR 20000 for Sweden.’; (c) in paragraph 3, points (a) to (f) are replaced by the following: ‘(a)for an ELISA testEUR 3 per test;(b)for a PCR testEUR 12 per test;(c)for the purchase of monovalent vaccinesEUR 0,36 per dose;(d)for the purchase of bivalent vaccinesEUR 0,54 per dose;(e)for the administration of vaccines to bovine animalsEUR 1,80 per bovine animal vaccinated, regardless of the number and types of doses used;(f)for the administration of vaccines to ovine or caprine animalsEUR 0,90 per ovine or caprine animal vaccinated, regardless of the number and types of doses used.’; 5. Article 5 is amended as follows: (a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; (b) paragraph 2(c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 1200000 for Belgium; (ii) EUR 25000 for Bulgaria; (iii) EUR 2100000 for the Czech Republic; (iv) EUR 340000 for Denmark; (v) EUR 1000000 for Germany; (vi) EUR 40000 for Estonia; (vii) EUR 120000 for Ireland; (viii) EUR 1000000 for Greece; (ix) EUR 1300000 for Spain; (x) EUR 660000 for France; (xi) EUR 1700000 for Italy; (xii) EUR 150000 for Cyprus; (xiii) EUR 1650000 for Latvia; (xiv) EUR 20000 for Luxembourg; (xv) EUR 2400000 for Hungary; (xvi) EUR 150000 for Malta; (xvii) EUR 3900000 for the Netherlands; (xviii) EUR 1200000 for Austria; (xix) EUR 4800000 for Poland; (xx) EUR 65000 for Portugal; (xxi) EUR 500000 for Romania; (xxii) EUR 120000 for Slovenia; (xxiii) EUR 600000 for Slovakia; (xxiv) EUR 75000 for the United Kingdom.’; (c) in paragraph 3, points (a) to (e) are replaced by the following: ‘(a)for a bacteriological test (cultivation/isolation)EUR 8,4 per test;(b)for the purchase of vaccineEUR 0,06 per dose;(c)for serotyping of relevant isolates of Salmonella spp.EUR 24 per test;(d)for a bacteriological test to verify the efficiency of disinfection of poultry houses after depopulation of a salmonella-positive flockEUR 6 per test;(e)for a test for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for salmonellaEUR 6 per test.’; 6. Article 6 is amended as follows: (a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; (b) paragraph 2(c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 120000 for Bulgaria; (ii) EUR 1600000 for Germany; (iii) EUR 240000 for France; (iv) EUR 160000 for Italy; (v) EUR 700000 for Hungary; (vi) EUR 700000 for Romania; (vii) EUR 30000 for Slovenia; (viii) EUR 300000 for Slovakia.’; (c) in paragraph 3, ‘EUR 2,5’ is replaced by ‘EUR 3’; 7. Article 8 is amended as follows: (a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; (b) paragraph 2(c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 90000 for Belgium; (ii) EUR 25000 for Bulgaria; (iii) EUR 70000 for the Czech Republic; (iv) EUR 80000 for Denmark; (v) EUR 300000 for Germany; (vi) EUR 10000 for Estonia; (vii) EUR 75000 for Ireland; (viii) EUR 50000 for Greece; (ix) EUR 150000 for Spain; (x) EUR 150000 for France; (xi) EUR 1000000 for Italy; (xii) EUR 20000 for Cyprus; (xiii) EUR 45000 for Latvia; (xiv) EUR 10000 for Lithuania; (xv) EUR 10000 for Luxembourg; (xvi) EUR 360000 for Hungary (xvii) EUR 20000 for Malta; (xviii) EUR 360000 for the Netherlands; (xix) EUR 60000 for Austria; (xx) EUR 100000 for Poland; (xxi) EUR 45000 for Portugal; (xxii) EUR 180000 for Romania; (xxiii) EUR 50000 for Slovenia; (xxiv) EUR 15000 for Slovakia; (xxv) EUR 25000 for Finland; (xxvi) EUR 50000 for Sweden; (xxvii) EUR 160000 for the United Kingdom.’; (c) in paragraph 3, points (a) to (e) are replaced by the following: ‘(a)ELISA testEUR 2,4 per test;(b)agar gel immune diffusion testEUR 1,44 per test;(c)HI test for H5/H7EUR 14,40 per test;(d)virus isolation testEUR 48 per test;(e)PCR testEUR 24 per test.’; 8. Article 9 is amended as follows: (a) in paragraph 2(c), ‘50 %’ is replaced by ‘60 %’; (b) paragraph 2(d) is replaced by the following: ‘(d) shall not exceed the following: (i) EUR 1900000 for Belgium; (ii) EUR 330000 for Bulgaria; (iii) EUR 1030000 for the Czech Republic; (iv) EUR 1370000 for Denmark; (v) EUR 7750000 for Germany; (vi) EUR 330000 for Estonia; (vii) EUR 4000000 for Ireland; (viii) EUR 2000000 for Greece; (ix) EUR 6650000 for Spain; (x) EUR 18850000 for France; (xi) EUR 6000000 for Italy; (xii) EUR 1700000 for Cyprus; (xiii) EUR 320000 for Latvia; (xiv) EUR 720000 for Lithuania; (xv) EUR 125000 for Luxembourg; (xvi) EUR 1180000 for Hungary; (xvii) EUR 25000 for Malta; (xviii) EUR 3530000 for the Netherlands; (xix) EUR 1800000 for Austria; (xx) EUR 3440000 for Poland; (xxi) EUR 1800000 for Portugal; (xxii) EUR 1000000 for Romania; (xxiii) EUR 250000 for Slovenia; (xxiv) EUR 550000 for Slovakia; (xxv) EUR 580000 for Finland; (xxvi) EUR 850000 for Sweden; (xxvii) EUR 6500000 for the United Kingdom.’; (c) in paragraph 3(d) ‘EUR 10’ is replaced by ‘EUR 12’; 9. Article 10, paragraph 2(c) is amended as follows: (a) in point (i) ‘EUR 1800000’ is replaced by ‘EUR 850000’; (b) in point (ii) ‘EUR 620000’ is replaced by ‘EUR 570000’; (c) in point (iv) ‘EUR 7110000’ is replaced by ‘EUR 8110000’; (d) in point (v) ‘EUR 5000000’ is replaced by ‘EUR 2100000’; (e) in point (vii) ‘EUR 200000’ is replaced by ‘EUR 290000’; 10. in Article 10 paragraph 4, ‘paragraphs 2 and 3’ is replaced by ‘paragraph 2(a), paragraph 2(b) and paragraph 3’; 11. Article 11, paragraph 5(c) is amended as follows: (a) in point (i) ‘EUR 2250000’ is replaced by ‘EUR 1600000’; (b) in point (ii) ‘EUR 1800000’ is replaced by ‘EUR 1500000’; (c) in point (v) ‘EUR 740000’ is replaced by ‘EUR 850000’; 12. in Article 11 paragraph 7, ‘paragraphs 5 and 6’ is replaced by ‘paragraph 5(a), paragraph 5(b) and paragraph 6’.

This Decision is addressed to the Member States.